Literature DB >> 8901827

Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.

S M Balakrishnan1, H D Wang, V Gopalakrishnan, T W Wilson, J R McNeill.   

Abstract

We determined changes in blood pressure, cardiac output, and total peripheral conductance evoked by intravenous infusions of angiotensin II (Ang II) in conscious, unrestrained normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) before and after pretreatment with bosentan, a nonselective endothelin antagonist. Blood pressure was recorded by radiotelemetry and cardiac output by ultrasonic transit-time flow probes. Bosentan per se failed to affect basal blood pressure and evoked only small changes in cardiac output and total peripheral conductance in both strains. The pressor effects of Ang II were exaggerated in SHR compared with WKY. Strikingly, bosentan pretreatment blunted the increases in blood pressure, the fall in cardiac output, and the decreases in conductance evoked by lower doses of Ang II but not higher doses of the peptide. This effect was observed in both rat strains but was more pronounced in SHR. These data suggest that endothelin contributes to the hemodynamic effects of Ang II in both SHR and WKY and that endothelin may contribute to the exaggerated pressor responsiveness of SHR to Ang II.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901827     DOI: 10.1161/01.hyp.28.5.806

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Endothelin mediates some of the renal actions of acutely administered angiotensin II.

Authors:  A Riggleman; J Harvey; C Baylis
Journal:  Hypertension       Date:  2001-07       Impact factor: 10.190

4.  Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  Olmesartan improves endothelin-induced hypertension and oxidative stress in rats.

Authors:  Li Yao; Hiroyuki Kobori; Matlubur Rahman; Dale M Seth; Takatomi Shokoji; Yuyan Fan; Guo-Xing Zhang; Shoji Kimura; Youichi Abe; Akira Nishiyama
Journal:  Hypertens Res       Date:  2004-07       Impact factor: 3.872

6.  Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.

Authors:  Suttira Intapad; Norma B Ojeda; Elliott Varney; Thomas P Royals; Barbara T Alexander
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

Review 7.  Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease.

Authors:  Radko Komers; Horacio Plotkin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-23       Impact factor: 3.619

Review 8.  Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.

Authors:  J Scott Miners; Jennifer C Palmer; Hannah Tayler; Laura E Palmer; Emma Ashby; Patrick G Kehoe; Seth Love
Journal:  Front Aging Neurosci       Date:  2014-09-11       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.